Epigenetics and aging

S Pal, JK Tyler - Science advances, 2016 - science.org
Over the past decade, a growing number of studies have revealed that progressive changes
to epigenetic information accompany aging in both dividing and nondividing cells …

MiR-137: an important player in neural development and neoplastic transformation

E Mahmoudi, MJ Cairns - Molecular psychiatry, 2017 - nature.com
MicroRNAs (miRNAs) represent an important class of small regulatory RNAs that control
gene expression posttranscriptionally by targeting mRNAs for degradation or translation …

Cholinergic system dysfunction and neurodegenerative diseases: cause or effect?

AM Tata, L Velluto, C D'Angelo… - CNS & Neurological …, 2014 - ingentaconnect.com
Acetylcholine (ACh) has been the first molecule to be identified as neurotransmitter. The
cholinergic and cholinoceptive areas, both in central and peripheral nervous system, have …

miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement

AG Hoss, A Labadorf, JC Latourelle, VK Kartha… - BMC medical …, 2015 - Springer
Background MicroRNAs (miRNAs) are small non-coding RNAs that recognize sites of
complementarity of target messenger RNAs, resulting in transcriptional regulation and …

Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease

L Lin, JW Park, S Ramachandran… - Human molecular …, 2016 - academic.oup.com
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by
a CAG expansion in the gene-encoding Huntingtin (HTT). Transcriptome dysregulation is a …

Long noncoding RNAs in aging and age-related diseases

S Kour, PC Rath - Ageing research reviews, 2016 - Elsevier
Aging is the universal, intrinsic, genetically-controlled, evolutionarily-conserved and time-
dependent intricate biological process characterised by the cumulative decline in the …

MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis

AG Hoss, VK Kartha, X Dong, JC Latourelle… - PLoS …, 2014 - journals.plos.org
Transcriptional dysregulation has long been recognized as central to the pathogenesis of
Huntington's disease (HD). MicroRNAs (miRNAs) represent a major system of post …

[HTML][HTML] From pathogenesis to therapeutics: a review of 150 years of Huntington's disease research

A Jiang, RR Handley, K Lehnert, RG Snell - International journal of …, 2023 - mdpi.com
Huntington's disease (HD) is a debilitating neurodegenerative genetic disorder caused by
an expanded polyglutamine-coding (CAG) trinucleotide repeat in the huntingtin (HTT) gene …

Repressor element-1 binding transcription factor (REST) as a possible epigenetic regulator of neurodegeneration and MicroRNA-based therapeutic strategies

A Nassar, S Satarker, PC Gurram, D Upadhya… - Molecular …, 2023 - Springer
Neurodegenerative disorders (NDD) have grabbed significant scientific consideration due to
their fast increase in prevalence worldwide. The specific pathophysiology of the disease and …

Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspective

LM Valor - Molecular neurobiology, 2015 - Springer
Transcriptional dysregulation in Huntington's disease (HD) is an early event that shapes the
brain transcriptome by both the depletion and ectopic activation of gene products that …